Under $200,000 per missile: U.S. Army’s target for Stinger successor

The U.S. Army seeks a third contender for its Next Generation Short Range Interceptor program, with a live-fire shootout planned for mid-2027. Companies have until Dec. 20 to submit solutions, aiming for under $200,000 per missile. Lockheed Martin and RTX’s Raytheon are already developing competing designs. The Army plans to invite top bidders to demonstrations in May and June 2027, with prototype awards in September 2027.

Original reporting
Published Nov 21, 2026, 1:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 21, 2026, 6:37 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Under $200,000 per missile: U.S. Army’s target for Stinger successor — source image
Decision brief

The 30-second read

$LMTBullishMed
01

Why it matters

The solicitation creates a near‑term catalyst for incumbent defense firms, especially Lockheed Martin and Raytheon, as they compete for a multi‑year contract.

02

Market read

First public disclosure of the Army's solicitation and budget, offering a material upside catalyst for the two incumbent defense contractors.

03

What to watch

Potential budget cuts or shifting defense priorities could reduce the contract size.

Relevance 7/10Novelty 7/10Timing: briefs due Dec 20 2026, demo May‑June 2027

Background

The U.S. Army issued a solicitation for a ready‑made alternate interceptor under the NGSRI program, with a $215 million development budget and a target of 11,000 missiles over ten years.

Company-level read

Ticker impact

$LMTBullishHigh confidence
Context

Lockheed Martin is a incumbent in the Army's Next Generation Short Range Interceptor program, with recent test flights and a potential contract award.

Expected impact

likely upside as investors price in possible contract win

Evidence & confidence

The Army is seeking prototypes and has allocated $215 million for development, creating a material upside catalyst for the incumbent.

$RTXBullishHigh confidence
Context

Raytheon (RTX) is the other incumbent in the NGSRI program, with recent test flights and a chance to win the Army contract.

Expected impact

likely upside as market anticipates a share of the $215 million development budget

Evidence & confidence

RTX is directly competing for the same Army program, making the solicitation a material catalyst.

Market effects

Boosts defense aerospace sector outlook as the Army expands short‑range air‑defense spending.

U.S. defense contractors may see modest gains; limited impact outside the sector.

Primarily U.S. defense market; minimal global spillover.

Counterpoint

If the Army selects a new entrant or delays the program, incumbent stocks could underperform.

Key entities

  • U.S. Army

    Issuing the NGSRI solicitation.

  • Lockheed Martin

    Incumbent competitor in the NGSRI program.

  • Raytheon (RTX)

    Incumbent competitor in the NGSRI program.

Related articles